These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 31174496)
1. A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer. Tsunoda A; Morikawa K; Inoue T; Miyazawa T; Hoshikawa M; Takagi M; Mineshita M BMC Cancer; 2019 Jun; 19(1):546. PubMed ID: 31174496 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites. Yoshimura K; Inoue Y; Karayama M; Tsuchiya K; Mori K; Suzuki Y; Iwashita Y; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Yokomura K; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H Lung Cancer; 2019 Aug; 134():202-209. PubMed ID: 31319982 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens. Sakata KK; Midthun DE; Mullon JJ; Kern RM; Nelson DR; Edell ES; Schiavo DN; Jett JR; Aubry MC Chest; 2018 Oct; 154(4):827-837. PubMed ID: 30059678 [TBL] [Abstract][Full Text] [Related]
4. EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer. Sakakibara R; Inamura K; Tambo Y; Ninomiya H; Kitazono S; Yanagitani N; Horiike A; Ohyanagi F; Matsuura Y; Nakao M; Mun M; Okumura S; Inase N; Nishio M; Motoi N; Ishikawa Y Clin Lung Cancer; 2017 Sep; 18(5):527-534.e1. PubMed ID: 28111119 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer. Mineura K; Hamaji M; Yoshizawa A; Nakajima N; Kayawake H; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Menju T; Chen-Yoshikawa TF; Date H Surg Today; 2020 Sep; 50(9):1049-1055. PubMed ID: 32166496 [TBL] [Abstract][Full Text] [Related]
6. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations. Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and reliability of evaluate PD-L1 expression determination using small biopsy specimens in non-small cell lung cancer. Chen M; Xu Y; Zhao J; Li J; Liu X; Zhong W; Wang M Thorac Cancer; 2021 Sep; 12(17):2339-2344. PubMed ID: 34291566 [TBL] [Abstract][Full Text] [Related]
8. PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer. Wang G; Ionescu DN; Lee CH; Hiruki T; Myers R; Shaipanich T; Lam S; Melosky B; Zhou C Lung Cancer; 2019 Oct; 136():1-5. PubMed ID: 31421256 [TBL] [Abstract][Full Text] [Related]
11. Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non-Small Cell Lung Cancer. Smith A; Wang H; Zerbo A; Beaudoin S; Ofiara L; Fiset PO; Benedetti A; Gonzalez AV J Bronchology Interv Pulmonol; 2020 Jan; 27(1):50-57. PubMed ID: 31513030 [TBL] [Abstract][Full Text] [Related]
12. Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study. Matsuoka H; Araya T; Kita T; Terada N; Yamamura K; Nishikawa S; Tambo Y; Sone T; Kimura H; Ooi A; Kasashima S; Kawashima A; Kasahara K J Cancer; 2021; 12(15):4478-4487. PubMed ID: 34149911 [No Abstract] [Full Text] [Related]
13. Correlation of programmed death-ligand 1 expression in tumour cells between diagnostic small biopsies performed by radial EBUS and surgical specimens of peripheral lung cancer. Lachkar S; Gervereau D; Loïc P; De Marchi M; Morisse H; Dantoing E; Piton N; Thiberville L; Salaün M; Guisier F BMJ Open Respir Res; 2024 Oct; 11(1):. PubMed ID: 39414327 [TBL] [Abstract][Full Text] [Related]
14. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience. Hardy J; Bhatt N; Medford ARL Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634 [TBL] [Abstract][Full Text] [Related]
15. Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological Specimens. Tajarernmuang P; Ofiara L; Beaudoin S; Wang H; Benedetti A; Gonzalez AV Chest; 2021 Aug; 160(2):743-753. PubMed ID: 33675792 [TBL] [Abstract][Full Text] [Related]
16. Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment. Gompelmann D; Sinn K; Brugger J; Bernitzky D; Mosleh B; Prosch H; Geleff S; Blessing A; Tiefenbacher A; Hoetzenecker K; Idzko M; Hoda MA J Cancer Res Clin Oncol; 2023 May; 149(5):1747-1754. PubMed ID: 35708777 [TBL] [Abstract][Full Text] [Related]
17. Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer. Kitazono S; Fujiwara Y; Tsuta K; Utsumi H; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Sasada S; Watanabe S; Asamura H; Tamura T; Ohe Y Clin Lung Cancer; 2015 Sep; 16(5):385-90. PubMed ID: 25937270 [TBL] [Abstract][Full Text] [Related]
18. Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non-small-cell lung cancer: The global, multicenter EXPRESS study. Dietel M; Savelov N; Salanova R; Micke P; Bigras G; Hida T; Antunez J; Guldhammer Skov B; Hutarew G; Sua LF; Akita H; Chan OSH; Piperdi B; Burke T; Khambata-Ford S; Deitz AC Lung Cancer; 2019 Aug; 134():174-179. PubMed ID: 31319978 [TBL] [Abstract][Full Text] [Related]
19. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer. Perrotta F; Nankivell M; Adizie JB; Maqsood U; Elshafi M; Jafri S; Lerner AD; Woolhouse I; Munavvar M; Evison M; Booton R; Baldwin DR; Janes SM; Kerr KM; Bianco A; Yarmus L; Navani N Chest; 2020 Sep; 158(3):1230-1239. PubMed ID: 32428509 [TBL] [Abstract][Full Text] [Related]
20. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer. Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]